814P Phase II study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Final analysis from EMPOWER-CSCC-1 groups 1, 2 and 3

M.R. Migden, C. Schmults, N. Khushanlani, A. Guminski, Anne Lynn S. Chang, K. Lewis, G. Ansstas, S.E. Bowyer, B.G.M. Hughes, D. Schadendorf, B. Modi, L. Dunn, L. Flatz, A. Hauschild, S-Y. Yoo, J. Booth, F.A. Seebach, I. Lowy, M.G. Fury, D. Rischin